Showing 11,841 - 11,860 results of 47,311 for search '(( 50 ((teer decrease) OR (a decrease)) ) OR ( 5 ((fold decrease) OR (mean decrease)) ))', query time: 1.14s Refine Results
  1. 11841
  2. 11842

    The effect of STOX1A on cell proliferation in the neuroblastoma cell-line SH-SY5Y. by Daan van Abel (214754)

    Published 2013
    “…(C) Overexpression and knockdown of STOX1A was determined with quantitative RT-PCR showing a mean 21 fold (mean ΔΔCt 4.4) increase in mRNA expression for STOX1A in stably transfected SH-SH5Y cells compared to the controls (Left bar) and a mean 71 fold (mean ΔΔCt 6.15) decreased mRNA expression for STOX1A siRNA transfected SH-SY5Y cells compared to the scrambled controls (right bar). …”
  3. 11843

    Inhibition of C5aR signaling and targeted complement inhibition alleviates liver injury. by Shihui Sun (180042)

    Published 2013
    “…<p>(A–I) Both C5aRmAb and CR2-fH groups displayed reduced liver damage (A–B, D–E, G–H) and decreased C3 deposition (C, F, I) 8 hours after LPS/D-GalN injection. …”
  4. 11844

    Production of O<sub>2</sub><sup>ꜙ</sup>, NO and cyclic GMP by 5-HT. by Marie Billaud (261506)

    Published 2009
    “…C, as measured by Elisa kit, basal cyclic GMP content (black column) was decreased by 5-HT (white column) whereas it was increased when PEG-SOD and PEG-catalase were added to 5-HT (light grey column). …”
  5. 11845

    PPM1A is critical for proliferation of intestinal organoids. by Ruyuan Zhou (10197187)

    Published 2021
    “…A dramatic lower number of de novo crypts (D, top panel) and the decreased size of organoids (D, bottom panel) were seen in organoids from PPM1A KO mice, with roughly 50 intestine organoids each group examined. …”
  6. 11846
  7. 11847

    Image_1_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.TIF by Hilde L. Orrem (5740313)

    Published 2018
    “…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”
  8. 11848

    Image_2_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.TIF by Hilde L. Orrem (5740313)

    Published 2018
    “…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”
  9. 11849

    Table_1_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.DOCX by Hilde L. Orrem (5740313)

    Published 2018
    “…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”
  10. 11850

    Presentation1_Ligand-bound integrin αvβ6 internalisation and trafficking.pdf by Amelia Meecham (13301040)

    Published 2022
    “…Integrins use endocytosis and trafficking as a means of regulating their surface expression and thus their functions, however little is known of how this process is regulated in the context of αvβ6. …”
  11. 11851

    Different maternal diet intervention differentially affected the number of macrophages infiltration. by Michelle Summerfield (6095900)

    Published 2018
    “…(C) Absolute percent area of CLS present in visceral adipose tissue determined H9N had a significant decrease compared to both NF and HF groups (n = 5–7, mean ±SEM). …”
  12. 11852
  13. 11853
  14. 11854
  15. 11855
  16. 11856
  17. 11857
  18. 11858
  19. 11859
  20. 11860